DE3120312C2 - Verfahren zur Herstellung von Darm-Glucagon-Antigenen und deren Verwendung - Google Patents
Verfahren zur Herstellung von Darm-Glucagon-Antigenen und deren VerwendungInfo
- Publication number
- DE3120312C2 DE3120312C2 DE3120312A DE3120312A DE3120312C2 DE 3120312 C2 DE3120312 C2 DE 3120312C2 DE 3120312 A DE3120312 A DE 3120312A DE 3120312 A DE3120312 A DE 3120312A DE 3120312 C2 DE3120312 C2 DE 3120312C2
- Authority
- DE
- Germany
- Prior art keywords
- asn
- peptide
- lys
- arg
- solution
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/575—Hormones
- C07K14/605—Glucagons
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/26—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against hormones ; against hormone releasing or inhibiting factors
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S436/00—Chemistry: analytical and immunological testing
- Y10S436/822—Identified hapten
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S436/00—Chemistry: analytical and immunological testing
- Y10S436/823—Immunogenic carrier or carrier per se
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
- Y10S530/806—Antigenic peptides or proteins
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S930/00—Peptide or protein sequence
- Y10S930/01—Peptide or protein sequence
- Y10S930/26—Containing cys-cys disulfide bridge between nonadjacent cysteine residues
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biophysics (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Endocrinology (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Immunology (AREA)
- Toxicology (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP6804080A JPS56163456A (en) | 1980-05-21 | 1980-05-21 | Preparation of antigen |
Publications (2)
Publication Number | Publication Date |
---|---|
DE3120312A1 DE3120312A1 (de) | 1982-03-04 |
DE3120312C2 true DE3120312C2 (de) | 1985-08-29 |
Family
ID=13362282
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE3120312A Expired DE3120312C2 (de) | 1980-05-21 | 1981-05-21 | Verfahren zur Herstellung von Darm-Glucagon-Antigenen und deren Verwendung |
Country Status (8)
Families Citing this family (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4572800A (en) * | 1982-09-30 | 1986-02-25 | Otsuka Pharmaceutical Co., Ltd. | Human leukemia virus-related peptides, a process for production thereof, antibodies of the peptides and a process for production of the antibodies |
CA1256795A (en) * | 1983-12-28 | 1989-07-04 | Dennis A. Carson | Anti-idiotype antibodies induced by synthetic polypeptides |
US4545985A (en) * | 1984-01-26 | 1985-10-08 | The United States Of America As Represented By The Secretary, Dept. Of Health And Human Services | Pseudomonas exotoxin conjugate immunotoxins |
GB2160312B (en) * | 1984-04-13 | 1987-09-16 | South African Inventions | Adjuvant for immunisation |
US4654419A (en) * | 1984-08-08 | 1987-03-31 | Scripps Clinic And Research Foundation | Synthetic polypeptides and antibodies related to epstein-barr virus nuclear antigen |
US5116725A (en) * | 1984-08-08 | 1992-05-26 | Scripps Clinic And Research Foundation | Assay for Epstein-Barr virus infection with solid phase bound synthetic polypeptides |
JPS62500452A (ja) * | 1984-09-19 | 1987-02-26 | ザ リ−ジエンツ オブ ザ ユニバ−シテイ オブ カリフオルニア | ヒト細胞形質転換に関連するレトロウイルスポリペプチド |
US4732863A (en) * | 1984-12-31 | 1988-03-22 | University Of New Mexico | PEG-modified antibody with reduced affinity for cell surface Fc receptors |
JPH0792458B2 (ja) * | 1986-03-14 | 1995-10-09 | 郁男 山科 | 糖鎖特異抗体アツセイプレ−ト及びその製造方法 |
US5202270A (en) * | 1986-05-15 | 1993-04-13 | Abbott Laboratories | Cocaine and cocaine metabolites assay tracers, immunogens and antibodies |
US6958148B1 (en) | 1998-01-20 | 2005-10-25 | Pericor Science, Inc. | Linkage of agents to body tissue using microparticles and transglutaminase |
US6919076B1 (en) | 1998-01-20 | 2005-07-19 | Pericor Science, Inc. | Conjugates of agents and transglutaminase substrate linking molecules |
EA201790377A1 (ru) | 2014-09-16 | 2017-08-31 | Регенерон Фармасьютикалз, Инк. | Антитела к глюкагону и их применения |
SG11201901355SA (en) | 2016-08-30 | 2019-03-28 | Regeneron Pharma | Methods of treating severe insulin resistance by interfering with glucagon receptor signaling |
EP3529278A1 (en) | 2016-10-20 | 2019-08-28 | Regeneron Pharmaceuticals, Inc. | Methods of lowering blood glucose levels |
EP3672620A1 (en) | 2017-08-22 | 2020-07-01 | Regeneron Pharmaceuticals, Inc. | Methods of treating urea cycle disorders by interfering with glucagon receptor signaling |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS5836308B2 (ja) * | 1977-02-10 | 1983-08-08 | 大塚製薬株式会社 | 抗体の製造方法 |
US4206199A (en) * | 1977-07-22 | 1980-06-03 | Takeda Chemical Industries, Ltd. | Novel glucagon fragment and its derivatives |
-
1980
- 1980-05-21 JP JP6804080A patent/JPS56163456A/ja active Granted
-
1981
- 1981-05-20 DK DK222081A patent/DK159163C/da not_active IP Right Cessation
- 1981-05-20 SE SE8103198A patent/SE454301B/sv not_active IP Right Cessation
- 1981-05-21 DE DE3120312A patent/DE3120312C2/de not_active Expired
- 1981-05-21 FR FR8110140A patent/FR2482861A1/fr active Granted
- 1981-05-21 BE BE0/204863A patent/BE888906A/fr not_active IP Right Cessation
- 1981-05-21 GB GB8115648A patent/GB2079289B/en not_active Expired
- 1981-05-21 US US06/265,926 patent/US4407965A/en not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
US4407965A (en) | 1983-10-04 |
JPS56163456A (en) | 1981-12-16 |
GB2079289A (en) | 1982-01-20 |
FR2482861A1 (fr) | 1981-11-27 |
JPS6223822B2 (US20030199744A1-20031023-C00003.png) | 1987-05-25 |
DK159163C (da) | 1991-02-11 |
DE3120312A1 (de) | 1982-03-04 |
GB2079289B (en) | 1983-10-26 |
SE454301B (sv) | 1988-04-18 |
SE8103198L (sv) | 1981-11-22 |
DK159163B (da) | 1990-09-10 |
FR2482861B1 (US20030199744A1-20031023-C00003.png) | 1983-09-09 |
BE888906A (fr) | 1981-11-23 |
DK222081A (da) | 1981-11-22 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE3120312C2 (de) | Verfahren zur Herstellung von Darm-Glucagon-Antigenen und deren Verwendung | |
DE3211263C2 (US20030199744A1-20031023-C00003.png) | ||
DE69432629T2 (de) | Antikörper gegen beta-amyloid oder derivative davon und seine verwendung | |
EP0783522B1 (de) | PEPTIDE AUS DER SEQUENZ DES hPTH (1-37) | |
DE2717741C2 (US20030199744A1-20031023-C00003.png) | ||
DE2858718C2 (US20030199744A1-20031023-C00003.png) | ||
DE214709T1 (de) | Synthetisches peptid und verfahren fuer dessen benutzung zum nachweis von antikoerpern zu htlv-iii, diagnose von aids und pre-aids-bedingungen und als impfstoffe. | |
DE2816841A1 (de) | Radioimmunologische bestimmung von prokollagen (typ iii) und prokollagen- peptid (typ iii) | |
EP0379949A2 (de) | Verfahren zur Bestimmung von HIV-Antikörpern | |
Lehman et al. | The FMRFamide-like neuropeptide of Aplysia is FMRFamide | |
EP0329994B1 (de) | Immunogen und seine Verwendung zur Gewinnung von Antikörpern gegen Hämoglobin A1C | |
DE3039122A1 (de) | Glucagonfragment und seine verwendung | |
EP0124779A2 (de) | Radioimmunverfahren für Thymosin beta 4 | |
DE3881467T2 (de) | Vasokonstriktor-Peptid. | |
DE2364883C2 (de) | Des-Lys↑2↑↑9↑-Ala↑3↑↑0↑-Schweine- und -Rinderinsulin, Verfahren zu deren Herstellung und diese Insuline enthaltende injizierbare Präparate | |
DE3040825A1 (de) | Neues tridekapeptid, verfahren zu seiner herstellung und verwendung | |
DE3014582C2 (US20030199744A1-20031023-C00003.png) | ||
DE3781745T2 (de) | Antikoerper zur verwendung fuer die bestimmung von menschlichem glycoalbumin. | |
Blache et al. | Development of an oxyntomodulin/glicentin C-terminal radioimmunoassay using a “thiol-maleoyl” coupling method for preparing the immunogen | |
DE2505712A1 (de) | Traegergebundene sowie biologisch aktive peptide und herstellungsverfahren dafuer | |
DE2804566A1 (de) | Polypeptide, verfahren zu ihrer herstellung und sie enthaltende arzneimittel | |
DE3876022T2 (de) | Calcitonin-derivate und deren salze. | |
DE2500579A1 (de) | Zwischenprodukte und derivate von secretin | |
EP0420043B1 (de) | Antikörper gegen hochkonservierte Aminosäuresequenzen von immunogenen Substanzen, Verfahren zur Herstellung dieser Antikörper, sowie deren Verwendung in Immunoassays | |
EP0446797B1 (de) | Synthetische Peptide, die Sequenzen aus Faktor VIIa enthalten und deren Verwendung |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
OP8 | Request for examination as to paragraph 44 patent law | ||
8125 | Change of the main classification |
Ipc: C07C103/52 |
|
8126 | Change of the secondary classification |
Free format text: A61K 37/02 G01N 33/54 |
|
D2 | Grant after examination | ||
8364 | No opposition during term of opposition | ||
8339 | Ceased/non-payment of the annual fee |